Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 12
Submit an article Journal homepage
125
Views
9
CrossRef citations to date
0
Altmetric
Review

The cost-effectiveness issue of adjuvant trastuzumab in early breast cancer

Jan Norum Professor, Department of Oncology, PO Box 13, University Hospital of North Norway, N-9038 Tromsø, Norway. [email protected]; Professor, Faculty of Medicine, University of Tromsø, N-9037 Tromsø, Norway
Pages 1617-1625 | Published online: 28 Jul 2006

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

J. Norum, J. A. Olsen, E. A. Wist & P. E. Lønning. (2007) Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis. Acta Oncologica 46:2, pages 153-164.
Read now

Articles from other publishers (8)

Noor Razilah Abdul Rafar, Yet Hoi Hong, David Bin-Chia Wu, Muhamad Faiz Othman & Chin Fen Neoh. (2019) Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review. Value in Health Regional Issues 18, pages 151-158.
Crossref
Virginie Nerich, Sopany Saing, Eva Maria Gamper, Georg Kemmler, Franck Daval, Xavier Pivot & Bernhard Holzner. (2016) Cost–utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment 159:3, pages 407-424.
Crossref
Vakaramoko Diaby, Rima Tawk, Vassiki Sanogo, Hong Xiao & Alberto J. Montero. (2015) A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer. Breast Cancer Research and Treatment 151:1, pages 27-40.
Crossref
Mohammad Vasei, Helmout Modjtahedi, Oreineb Ale-booyeh, Ahmad Mosallaei, Abdol Mohammad Kajbafzadeh, Mehdi Shahriari, Abbas Ali Ghaderi, Hossein Soleymanpour, Farid Kosari, Holger Moch & Guido Sauter. (2009) Amplification and expression of EGFR and ERBB2 in Wilms tumor. Cancer Genetics and Cytogenetics 194:2, pages 88-95.
Crossref
Guido SauterJames LeeJohn M.S. BartlettDennis J. SlamonMichael F. Press. (2009) Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations. Journal of Clinical Oncology 27:8, pages 1323-1333.
Crossref
Louis P. GarrisonJrJr, Deborah Lubeck, Deepa Lalla, Virginia Paton, Amylou Dueck & Edith A. Perez. (2007) Cost‐effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2‐positive breast cancer. Cancer 110:3, pages 489-498.
Crossref
. 2007. The Biology of Cancer. The Biology of Cancer 171 193 .
Christopher Nicholson. 2007. Heart Failure. Heart Failure 233 253 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.